References
<A NAME="RU17804ST-1A">1a</A>
Soine TO.
J. Pharm. Sci.
1964,
53:
231
<A NAME="RU17804ST-1B">1b</A>
Chen CH.
Fox JL.
Proc. Int. Conf. Lasers
1987,
995
<A NAME="RU17804ST-1C">1c</A>
Edelson RL.
Sci. Am.
1988,
August:
68
<A NAME="RU17804ST-1D">1d</A>
Dini A.
Ramundo E.
Saturnino P.
Scimone A.
Stagno d’Alcontres I.
Boll. Soc. Ital. Biol. Sper.
1992,
68:
453
<A NAME="RU17804ST-1E">1e</A>
Hoult JR.
Paya M.
Gen. Pharmacol.
1996,
27:
713
<A NAME="RU17804ST-1F">1f</A>
Rocha L.
Marston A.
Kaplan M.
Stoeckli-Evans H.
Thull U.
Testa B.
Hostettmann K.
Phytochemistry
1994,
36:
1381
<A NAME="RU17804ST-1G">1g</A>
Levine C.
Hiasa H.
Marians KJ.
Biochim. Biophys. Acta
1998,
29:
1400
<A NAME="RU17804ST-1H">1h</A>
Vlietinck AJ.
De Bruyne T.
Apers S.
Pieters LA.
Planta Med.
1998,
64:
97
<A NAME="RU17804ST-1I">1i</A>
Murakami A.
Gao G.
Omura M.
Yano M.
Ito C.
Furukawa H.
Takahashi D.
Koshimizu K.
Ohigashi H.
Bioorg. Med. Chem. Lett.
2000,
10:
59
<A NAME="RU17804ST-1J">1j</A>
Raboin J.-C.
Beley M.
Kirsch G.
Tetrahedron Lett.
2000,
41:
1175
For reviews, see:
<A NAME="RU17804ST-2A">2a</A>
Egan D.
Okennedy R.
Moran E.
Cox D.
Prosser E.
Thornes RD.
Drug Metab. Rev.
1990,
22:
503
<A NAME="RU17804ST-2B">2b</A>
Pineo GF.
Hull RD.
Drug Safety
1993,
9:
263
<A NAME="RU17804ST-2C">2c</A>
Murray RDH.
Nat. Prod. Rep.
1995,
12:
477
<A NAME="RU17804ST-2D">2d</A>
Trivedi KN.
Rao SSM.
Mistry SV.
Desai SM.
J. Indian Chem. Soc.
2001,
78:
579
<A NAME="RU17804ST-3A">3a</A>
Awasthi AK.
Tewari RS.
Synthesis
1986,
1061
<A NAME="RU17804ST-3B">3b</A>
Sato K.
Inour S.
Kobayashi T.
Ota T.
Tazaki M.
J. Chem. Soc., Perkin Trans. 1
1987,
1753
<A NAME="RU17804ST-3C">3c</A>
Desouza MD.
Joshi V.
Indian J. Heterocycl. Chem.
1993,
3:
93
<A NAME="RU17804ST-3D">3d</A>
Ivanova DI.
Eremin SV.
Shvets VI.
Tetrahedron
1996,
52:
9581
<A NAME="RU17804ST-3E">3e</A>
Lee YR.
Kim BS.
Wang HC.
Tetrahedron
1998,
54:
12215
<A NAME="RU17804ST-3F">3f</A>
De la Hoz A.
Moreno A.
Vazquez E.
Synlett
1999,
608
<A NAME="RU17804ST-3G">3g</A>
Yavari I.
Adib M.
Hojabri L.
Tetrahedron
2001,
57:
7537
<A NAME="RU17804ST-3H">3h</A>
Gonzalez-Gomez JC.
Santana L.
Uriarte E.
Synthesis
2002,
43
<A NAME="RU17804ST-3I">3i</A>
Bose DS.
Rudradas AP.
Babu MH.
Tetrahedron Lett.
2002,
43:
9195
<A NAME="RU17804ST-3J">3j</A>
Song AM.
Wang XB.
Lam KS.
Tetrahedron Lett.
2003,
44:
1755
<A NAME="RU17804ST-3K">3k</A>
Kaye PT.
Musa MA.
Synth. Commun.
2003,
33:
1755
<A NAME="RU17804ST-3L">3l</A>
Pave G.
Chalard P.
Viaud-Massuard MC.
Synlett
2003,
987
<A NAME="RU17804ST-3M">3m</A>
Fringuelli F.
Piermatti O.
Pizzo F.
Synthesis
2003,
2331
<A NAME="RU17804ST-3N">3n</A>
Selles P.
Mueller U.
Org. Lett.
2004,
6:
277
<A NAME="RU17804ST-3O">3o</A>
Kontogiorgis CA.
Hadjipavlou-Litina DJ.
Bioorg. Med. Chem. Lett.
2004,
14:
611
<A NAME="RU17804ST-4">4</A>
Kadnikov DV.
Larock RC.
Org. Lett.
2000,
2:
3643
<A NAME="RU17804ST-5">5</A>
Boland GM.
Donnelly DMX.
Finet J.-P.
Rea MD.
J. Chem. Soc., Perkin Trans. 1
1996,
2591
<A NAME="RU17804ST-6">6</A>
Yao M.-L.
Deng M.-Z.
Heteroat. Chem.
2000,
11:
380
<A NAME="RU17804ST-7">7</A>
Wu J.
Liao Y.
Yang Z.
J. Org. Chem.
2001,
66:
3642
<A NAME="RU17804ST-8">8</A>
Wu J.
Yang Z.
J. Org. Chem.
2001,
66:
7875
<A NAME="RU17804ST-9">9</A>
Saleem R.
Faizi S.
Deeba F.
Siddiqui BS.
Qazi MH.
Planta Med.
1997,
63:
454
<A NAME="RU17804ST-10">10</A>
Lin G.-Q.
Hong R.
J. Org. Chem.
2001,
66:
2877
<A NAME="RU17804ST-11">11</A>
Pharkphoom P.
Hiroshi N.
Wanchai DE.
Planta Med.
1998,
64:
774
<A NAME="RU17804ST-12">12</A>
Lei J.-G.
Lin G.-Q.
Chin. J. Chem.
2002,
20:
1263
<A NAME="RU17804ST-13A">13a</A>
Percec V.
Bae J.-Y.
Zhao M.
Hill DH.
J. Org. Chem.
1995,
60:
176
<A NAME="RU17804ST-13B">13b</A>
Percec V.
Bae J.-Y.
Hill DH.
J. Org. Chem.
1995,
60:
1060
<A NAME="RU17804ST-13C">13c</A>
Percec V.
Bae J.-Y.
Zhao M.
Hill DH.
J. Org. Chem.
1995,
60:
1066
<A NAME="RU17804ST-13D">13d</A>
Percec V.
Golding GM.
Smidrkal J.
Weichold O.
J. Org. Chem.
2004,
69:
3447
<A NAME="RU17804ST-14">14</A>
General Procedure for the Synthesis of 7: To an oven-dried Schlenk flask (25 mL) was charged 4-coumarin compound 3 (0.5 mmol), NiCl2
(PPh3)2 (0.2 equiv), PPh3 (0.4 equiv), zinc dust (2.2 mmol) and dry toluene (3 mL) under argon. The resulting
mixture was heated to 90 °C. The aryl halide 5 (0.6 mmol) was then added dropwise through micro-syringe pump over 3 h. After the
addition, the reaction mixture was stirred at the same temperature until completion.
The reaction mixture was cooled down to r.t., quenched with 5% HCl and diluted by
CH2Cl2. The mixture was stirred vigorously at r.t. until the solution was clear. The organic
layer was separated and the water layer was extracted with CH2Cl2 (3 × 10 mL). The combined organic layer was washed with sat. aq NaHCO3, brine, and dried over Na2SO4. The solution was concentrated under vacuum; the obtained residue was purified by
silica column chromato-graphy to give the corresponding cross-coupling product 7 (selected characterization data of 7 are listed as follows).
<A NAME="RU17804ST-15">15</A>
Compound 7c. 1H NMR (300 MHz, CDCl3): d = 9.69 (s, 1 H), 7.86 (m, 1 H), 7.54 (m, 1 H), 7.45 (m, 1 H), 7.22-7.16 (m, 2
H), 7.01 (m, 1 H), 6.40 (s, 1 H), 4.05 (s, 3 H), 3.70 (s, 3 H). MS (EI): m/z (%) = 310 (71) [M+], 295 (100). IR (KBr): 3088, 2947, 2837, 2733, 1729, 1695, 1683, 1604, 1584, 1566
cm-1. Anal. Calcd for C18H14O5: C, 69.67; H, 4.55. Found: C, 69.86; H, 4.57.
<A NAME="RU17804ST-16">16</A>
Compound 7f. 1H NMR (300 MHz, CDCl3): d = 8.08 (d, J = 2.1 Hz, 1 H), 7.64 (s, 1 H), 7.54 (d, J = 7.5 Hz, 1 H), 7.51 (d, J = 7.5 Hz, 1 H), 7.42-7.21 (m, 4 H), 6.45 (d, J = 2.1 Hz, 1 H), 3.93 (s, 3 H). 13C NMR (75.5 MHz, CDCl3): d = 175.12, 160.67, 157.84, 154.08, 153.90, 151.45, 148.05, 132.41, 127.02, 124.91,
124.52, 120.90, 120.03, 118.95, 117.70, 117.45, 105.45, 56.28. MS (EI): m/z (%) = 320 (4) [M+], 292 (10.00). IR (KBr): 3078, 2963, 1720, 1649, 1610, 1488, 1446, 1334, 1271 cm-1. HRMS: m/z calcd for C19H12O5: 320.0685; found: 320.0734.
<A NAME="RU17804ST-17">17</A>
Compound 7h. 1H NMR (300 MHz, CDCl3): δ = 8.05 (s, 1 H), 7.65 (s, 1 H), 7.55-7.30 (m, 4 H), 7.11 (s, 1 H), 6.42 (s, 1
H), 3.94 (s, 3 H), 2.34 (s, 3 H). 13C NMR (75.5 MHz, CDCl3): δ = 174.84, 160.58, 157.73, 153.66, 151.79, 151.20, 147.65, 133.95, 133.21, 126.31,
124.64, 120.69, 119.76, 118.46, 117.47, 116.90, 105.26, 59.01, 20.91. MS (EI):
m/z (%) = 335 (18) [M+ + 1], 334 (78) [M+], 333 (21) [M+ - 1], 306 (100). IR (KBr): 3078, 2959, 2929, 2498, 1719, 1698, 1646, 1618, 1568,
1488, 821 cm-1. HRMS: m/z calcd for C20H14O5: 334.0841; found: 334.0874.
<A NAME="RU17804ST-18">18</A>
Compound 7j. 1H NMR (300 MHz, CDCl3): δ = 9.70 (s, 1 H), 7.54-7.30 (m, 5 H), 6.80 (s, 1 H), 6.39 (d, J = 15 Hz, 2 H). MS (EI): m/z (%) = 312 (71) [M+], 269 (100). IR (KBr): 3075, 2913, 2861, 1725, 1682, 1610, 1571, 1504, 1482, 1440,
1369, 1268, 1253 cm-1. HRMS: m/z calcd for C17H9FO5: 312.0434; found: 312.0385.
<A NAME="RU17804ST-19">19</A>
Compound 7m. 1H NMR (300 MHz, CDCl3): δ = 10.16 (s, 1 H), 8.09 (d, J = 9.0 Hz, 2 H), 7.89 (d, J = 9.0 Hz, 2 H), 7.74-7.58 (m, 4 H), 7.37 (d, J = 9.3 Hz, 1 H), 7.16 (d, J = 8.7 Hz, 1 H), 6.51 (s, CH, 1 H). MS (EI): m/z (%) = 301 (20) [M+ + 1], 300 (91) [M+], 272 (100). IR (KBr): 1733, 1631, 1601, 1549, 1500, 1470, 1375, 1209 cm-1. HRMS: m/z calcd for C20H12O3: 300.0786; found: 300.0809.